Fred Hrkac is President of Europe, Middle East & Africa (EMEA) for Boston Scientific.
Before joining Boston Scientific in 2009, Fred was Worldwide President of Sorin Group CRM where he was responsible for all global business units and sales of more than $350 million. Previously at Sorin, he was Vice President of Global Marketing & Sales responsible for sales of $310 million in a matrix sales organization. Prior to Sorin, Fred spent 14 years with Johnson & Johnson (J&J), where he served in various marketing and senior management positions, including Vice President of International at Biosense Webster (a J&J company).
Fred graduated from Wilfrid Laurier University in Ontario, Canada where he earned an honors bachelor’s degree in Business Administration.
Maulik Nanavaty is President of Japan for Boston Scientific.
Maulik joined Boston Scientific in 2005 as Vice President for Corporate Strategy for Japan, where he led a successful business transformation and contributed to a high level of operational efficiency. Most recently, Maulik was Vice President and General Manager of Japan's Interventional Cardiology business. During his tenure, Maulik managed the successful launch of the Company's TAXUS® Express2™ drug-eluting stent system in Japan. Prior to joining Boston Scientific, Maulik served for 16 years in various executive positions at Baxter International, Inc., and Baxter Japan.
Maulik holds a Ph.D. in Pharmaceutical Sciences from the University of Illinois and an M.B.A. from the University of Chicago.
Mark Paul is President of Neurovascular for Boston Scientific.
Mark joined Boston Scientific in 1991 as territory manager for its Medi-Tech division. Most recently, he served as Vice President and General Manager of Boston Scientific International, leading 10 international business franchises and marketing support functions. Previously, Mark held a variety of marketing positions in the Company’s Peripheral Interventions, Neurovascular, Oncology and Vascular Surgery businesses. He was Boston Scientific's first Neurovascular product manager and subsequently held a series of marketing positions with increasing management responsibility, including Director of Marketing in Europe for the Company's Peripheral Interventions, Oncology and Vascular Surgery businesses.
Prior to Boston Scientific, Mark held a variety of sales management positions with Procter & Gamble’s paper and soap divisions.
Mark holds a B.A. from the University of Utah.